Your browser doesn't support javascript.
loading
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity.
Zhao, Xueer; Zhang, Yueru; Trejo-Cerro, Oscar; Kaplan, Ecem; Li, Zhe; Albertsboer, Femke; El Hammiri, Neyla; Mariz, Filipe Colaço; Banks, Lawrence; Ottonello, Simone; Müller, Martin.
Afiliação
  • Zhao X; Tumorvirus-specific Vaccination Strategies, German Cancer Research Center, Heidelberg, Germany. x.zhao@dkfz-heidelberg.de.
  • Zhang Y; Tumorvirus-specific Vaccination Strategies, German Cancer Research Center, Heidelberg, Germany.
  • Trejo-Cerro O; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Kaplan E; Tumorvirus-specific Vaccination Strategies, German Cancer Research Center, Heidelberg, Germany.
  • Li Z; B Cell Immunology, German Cancer Research Center, Heidelberg, Germany.
  • Albertsboer F; Tumorvirus-specific Vaccination Strategies, German Cancer Research Center, Heidelberg, Germany.
  • El Hammiri N; Tumorvirus-specific Vaccination Strategies, German Cancer Research Center, Heidelberg, Germany.
  • Mariz FC; Tumorvirus-specific Vaccination Strategies, German Cancer Research Center, Heidelberg, Germany.
  • Banks L; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Ottonello S; Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
  • Müller M; Tumorvirus-specific Vaccination Strategies, German Cancer Research Center, Heidelberg, Germany. martin.mueller@dkfz-heidelberg.de.
NPJ Vaccines ; 9(1): 119, 2024 Jun 26.
Article em En | MEDLINE | ID: mdl-38926425

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha